Skip to main content
Back to 5Y Capital

5Y Capital's Pharmaceutical Portfolio

Browse 9 Pharmaceutical companies funded by 5Y Capital. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
9
Total Funding in Pharmaceutical
$644.3M

Pharmaceutical Portfolio Companies (9)

Export
BiotechnologyPharmaceutical

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Laguna Hills, United States
April 2026
$23.4M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

Chengdu, China
January 2026
$86.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Allink Biotherapeutics is a biopharmaceutical company that develops multi-specific antibodies for oncology and immunology treatment.

Shanghai, China
December 2025
$47.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Hangzhou, China
August 2025
$55.7M
Series D

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

Cambridge, United States
February 2022
$10.0M
Angel

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalPharmaceutical

Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders.

Shenzhen, China
December 2021
$100.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery.

New York, United States
December 2021
$15.0M
Seed

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware

Taimei Technology provides a cloud platform for clinical research collaboration.

Jiaxing, China
September 2020
$176.2M
Series Unknown

Founder Contacts

19,000+ verified contacts

Explore 5Y Capital's Full Portfolio

View all companies funded by 5Y Capital across every industry and funding stage.

View Full 5Y Capital Portfolio